 |
Trial Information
Summary: Social Anxiety Disorder Treatment and fMRIThe purpose of this phase IV study is to examine the effect of paroxetine (Paxil) treatment on brain activation patterns among persons with social anxiety. Psychiatric and medical evaluation to determine eligibility 12 weeks of treatment with paroxetine (Paxil), a medication approved for the treatment of social anxiety disorder Two visits for functional Magnetic Resonance Imaging (fMRI) scans while viewing pictures; one scan before and one after 8-12 weeks of treatment. Participants will be compensated $100 after each scan. IRB # 5448 Patient Inclusion Criteria
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received. This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Trial listings updated: June 1, 2008 at 6:32:00 AM |
|
|
Patient Resources: [ Trial Listing
] [ Notification Services ] [ Drug
Directories ]
Copyright © 1995 - 2008, CenterWatch |
